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Background
Microarray  expression  profiling  has  proven  to  be  a 
valuable technology in a wide variety of biological and 
biomedical  investigations.  One  of  its  limitations, 
however,  is  the  relatively  large  amount  of  mRNA 
required.  Consequently,  for  analyses  involving  tissue 
from humans or experimental animals, the tissue samples 
used for mRNA extraction are often heterogeneous with 
regard  to  cell  type.  Because  gene  expression  can  vary 
substantially among cell types, gene expression profiles 
based on tissue samples of varying composition can be 
very  difficult  to  interpret  biologically.  The  problem  is 
particularly serious for expression profiles intended for 
clinical  use  in  informing  treatment  selection. 
Investigators have reported difficulties caused by sample 
heterogeneity  for  identifying  biologically  relevant 
differentially  expressed  genes  and  for  developing  and 
validating  predictive  models  [1-3].  Although  laser 
capture microdissection provides an experimental means 
for selecting a more homogeneous population of cells, it 
is  time  consuming  and  difficult  to  obtain  sufficient 
purified tissue with adequately preserved RNA.
Expression deconvolution
Several  statistical  approaches  have  been  proposed  to 
deconvolute  gene  expression  profiles  obtained  from 
heterogeneous  tissue  samples  into  cell-type-specific 
subprofiles.  Most  of  the  methods  are  based  on  a 
framework  first  proposed  by  Venet  et  al.  [4], 
incorporating  the  linearity  assumption  that  the 
expression of each gene in a mixture of cell types is a 
weighted  average  of  the  expression  values  that  would 
exist for pure populations of those cell types. The weights 
are determined by the proportional composition of the 
cell types in the mixture and hence are the same for each 
gene  but  differ  among  sample  mixtures.  Since  the 
publication  of  Venet  et  al.  [4],  several  additional 
publications have appeared dealing with deconvolution 
of  gene  expression  profiles  on  complex  tissues  (for 
example,  [5-10]).  Without  reviewing  the  details  that 
distinguish  the  various  methods,  we  attempt  here  to 
summarize the status of this area of development.
When the proportions of the cell types in each mixture 
sample  are  known  from  fluorescence  activated  cell 
sorting  analysis,  histopathological  evaluation  or  other 
experimental  methods,  deconvolution  is  relatively 
straightforward. With the known proportions of the cell 
types in the mixture, deconvolution can be solved as a 
linear regression problem in which the cell-type-specific 
gene  expression  levels  represent  the  regression  coeffi-
cients.  In  fact,  under  these  conditions,  the  regression 
problem can be solved separately for each gene.
In  some  cases  the  cell-type-specific  gene  expression 
levels may be of interest in their own right, or interest 
may focus on differences in expression among cell types. 
For  cancer  studies,  however,  interest  is  often  on 
differential expression among classes of tumors (such as 
Abstract
Cell type heterogeneity may have a substantial effect 
on gene expression profiling of human tissue. Several 
in silico methods for deconvoluting a gene expression 
profile into cell-type-specific subprofiles have been 
published but not widely used. Here, we consider 
recent methods and the experimental validations 
available for them. Shen-Orr et al. recently developed 
an approach called cell-type-specific significance 
analysis of microarray for deconvoluting gene 
expression. This method requires the measurement of 
the proportion of each cell type in each sample and 
the expression profiles of the heterogeneous samples. 
It determines how gene expression varies among 
pre-defined phenotypes for each cell type. Gene 
expression can vary substantially among cell types 
and sample heterogeneity can mask the identification 
of biologically important phenotypic correlations. 
Consequently, the deconvolution approach can be 
useful in the analysis of mixtures of cell populations in 
clinical samples.
© 2010 BioMed Central Ltd
Gene expression deconvolution in clinical samples
Yingdong Zhao and Richard Simon*
COMMENTARY
*Correspondence: rsimon@mail.nih.gov 
Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National 
Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Zhao Y, Simon R Genome Medicine 2010, 2:93 
http://genomemedicine.com/content/2/12/93
© 2010 BioMed Central Ltdresponders versus non-responders to a treatment), with 
expression  from  normal  epithelium  and  infiltrating 
immune  cells  of  lesser  interest.  Shen-Orr  et  al.  [8] 
developed  cell-type-specific  significance  analysis  of 
microarray (csSAM) for analyzing differentially expressed 
genes  for  each  cell  type  in  sample  mixtures  with 
microarray  data.  The  relationship  between  measured 
gene expression in mixed samples and the expression of 
genes  in  the  isolated  pure  subsets  was  tested 
experimentally for synthetic mixtures of liver, brain and 
lung cells from rats. Their in silico synthesized mixture 
expression  profiles,  obtained  by  multiplying  the 
measured  pure  tissue  expression  profiles  by  the 
proportion of the tissue subset in a given mixture sample, 
were highly correlated with the experimentally measured 
expression profiles for the mixtures. This provided direct 
support  for  the  linearity  assumption  of  all  previous 
models. The deconvoluted estimates of cell-type-specific 
expression  were  in  good  agreement  with  expression 
measured in pure cell types for the vast majority of probes.
The authors [8] then applied csSAM to human whole 
blood gene expression array data from kidney transplant 
recipients.  When  they  used  the  whole  blood  analyses, 
there  were  no  differentially  expressed  genes  detected 
between the rejection group and stable group. However, 
a  large  number  of  differentially  expressed  genes  were 
identified between the two groups in two individual cell 
types  when  applying  the  csSAM  for  each  of  the  five 
quantified  cell  types:  monocyte,  basophile,  neutrophil, 
eosinophil and lymphocyte. The method requires experi-
mental measurements of the proportional composition of 
the component cell types in each sample. Although there 
are  some  pre-processing  issues  such  as  normalization 
that require further consideration, csSAM seems to be a 
useful  tool  for  analysis  of  gene  expression  profiling  of 
heterogeneous  samples  with  known  relative  cell  type 
frequencies. Source code for csSAM in the R statistical 
programming language is available [8].
Several investigations performed deconvolution when 
the  proportions  of  the  component  cell  types  were 
unknown but expression of signature genes in pure cell 
types was known (for example, [5-7]). Abbas et al. [7] 
developed  an  approach  to  estimate  the  proportions  of 
white blood cell subtypes in samples from patients with 
systemic  lupus  erythematosus.  First,  they  selected  the 
most highly expressed signature probesets (genes) among 
several of the 18 immune cell types of interest using the 
expression  data  from  the  pure  cells.  They  then  used 
expression profiles for these signature genes to solve a 
linear equation for the proportions of the 18 immune cell 
subtypes in both healthy donors and patients with lupus. 
The deconvoluted results allowed them to find patterns 
of leukocyte dynamics and their correlations with clinical 
outcomes. In circumstances such as described by Abbas 
et al. [7] in which careful preliminary studies have been 
conducted  to  identify  signature  genes  and  determine 
their expression in pure cell subtypes, such deconvolution 
can be successful.
Some proposals for deconvolution have been made for 
cases in which neither the proportions of the cell types in 
the  mixtures  nor  signature  genes  are  known.  These 
approaches  use  a  variety  of  methods,  such  as  non-
negative  matrix  factorization  [9,10].  The  validations 
available are limited, however, and the number of samples 
required  for  accurate  deconvolution  may  be  large  [9]. 
Consequently, when measurements of the proportions of 
the component cell types in individual samples are not 
available and signature genes for each cell subtype are 
unknown, we believe that the status of deconvolution of 
expression profiles of mixtures is less clear.
Identifying  genes  that  are  differentially  expressed 
among groups of diseased tissue samples is a frequent 
objective  of  gene  expression  profiling.  Many  of  the 
publications  referenced  here  ignore  class  information 
(such as disease versus normal or responder versus non-
responder) in performing the deconvolution and state 
or  imply  that  the  deconvoluted  cell-type-specific 
expression  profiles  can  then  be  used  with  standard 
software  packages  for  investigating  class  comparisons 
[6,10]. This approach is potentially problematic, however, 
because  the  deconvoluted  expression  profiles  are  no 
longer  statistically  independent.  Shen-Orr  et  al.  [8] 
indicate  that  the  deconvolution  should  be  performed 
separately  for  each  class  being  compared  and  that  in 
using permutation tests to assess statistical significance, 
deconvolution should be repeated for each permutation 
of class labels.
Conclusions
Deconvolution  of  gene  expression  profiles  for 
heterogeneous  samples  can  be  performed  accurately 
when sufficiently accurate estimates of the proportional 
representation of component cell types in each sample 
are  available  and  when  expression  profiles  of  the 
components  are  sufficiently  different.  The  csSAM 
method developed by Shen-Orr et al. [8] can be useful in 
such clinical applications. Further studies are needed to 
address potential confounding factors for deconvolution, 
such as data normalization and batch effect adjustment. 
As Shen-Orr et al. [8] indicated, although the assumption 
of  linearity  holds  for  majority  of  probes,  identification 
and  exclusion  of  probes  affected  by  non-linear 
amplification  or  synergistic  cross-hybridization  may 
provide more accurate deconvolution. Although most of 
the  previous  deconvolution  methods  have  focused  on 
single-label  microarray  data,  they  could  be  potentially 
adapted  for  use  with  dual-label  array  that  uses  a 
homogeneous reference sample.
Zhao Y, Simon R Genome Medicine 2010, 2:93 
http://genomemedicine.com/content/2/12/93
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the proportional representation of component cell types 
in  each  sample  are  not  available  can  be  performed 
accurately in cases, such as that of Abbas et al. [7], in 
which careful preliminary studies have been conducted 
to  identify  expression  profiles  of  signature  genes  from 
pure  samples  that  clearly  distinguish  the  cell  types. 
Without the prior identification of such signature genes 
or the measurement of cell-type proportions, however, 
methods  for  the  deconvolution  of  gene  expression 
profiles  for  mixed  tissue  samples  require  further 
investigation and experimental validation to clarify the 
conditions under which accurate results can be obtained.
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